Mansour A. Parsi, MD Department of Gastroenterology and Hepatology, The Cleveland Clinic Foundation
Ashish Atreja, MD Department of Gastroenterology and Hepatology, The Cleveland Clinic Foundation
Nizar N. Zein, MD Department of Gastroenterology and Hepatology, The Cleveland Clinic Foundation
Address: Mansour A. Parsi, MD, Department of Gastroenterology and Hepatology, A31, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail parsim@ccf.org
This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.
ABSTRACTRecent studies have shown that spontaneous bacterial peritonitis (SBP) is more common than previously thought among patients admitted to the hospital with cirrhotic ascites. Other recent studies have clarified which antibiotic regimens are most successful for treatment and prevention, often shortening the duration of treatment. Still, the prognosis is poor and recurrence of SBP is common.